Clinical Trial Update: A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers [Phase 3]

View source ↗

Summary

This Phase 3 double-blind trial of an RSV maternal unadjuvanted vaccine in pregnant women and their infants was terminated, and results were posted on 2024-09-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• RSV maternal unadjuvanted vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: TERMINATED | Results posted: 2024-09-05